DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 74 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCorporate Action

Bliss GVS Pharma Limited — Alteration Of Capital and Fund Raising-XBRL

NSE 2 hrs ago·4 Sept 2026, 1:37 pm

Bliss GVS Pharma

Bliss GVS Pharma has informed the stock exchanges about the allotment of securities, which is a formal step in raising fresh capital. This action is part of the company's ongoing strategy to bolster its financial position and fund future growth initiatives.

For investors, this development signals that the company is actively seeking resources to expand its operations or reduce debt. It reflects management's confidence in the business and can be a positive indicator of long-term planning.

Investors should monitor the specific use of these funds and the company's subsequent financial performance to gauge the effectiveness of this capital raise.